Affymetrix's Q3 Revenues Increase 4 Percent; Shares Sink on Estimates Miss

Affy's revenues rose on product sales and service revenues. Its top and bottom line results missed analysts' estimates, causing its shares to drop sharply.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories